author-photo

Michael J. Campbell

University of California, San Francisco
Stanford University

83

Papers

5539

Citations

Citation Trend

Filter By

Papers (70) Sort By

Journal Conference Others

Evaluation of intra-tumoral (IT) SD-101 and pembrolizumab (Pb) in combination with paclitaxel (P) followed by AC in high-risk HER2-negative (HER2-) stage II/III breast cancer: Results from the I-SPY 2 trial.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Abstract GS2-01: The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Germline genetic contribution to the immune landscape of cancer.

2021 Immunity
Show All
- Source
- Cite
- Save
Citations (20)
Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection.

2021
Show All
- Source
- Cite
- Save
Citations (1)
Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence.

2021 Journal of Mammary Gland Biology and Neoplasia
Show All
- Source
- Cite
- Save
Citations (8)
Germline genetic contribution to the immune landscape of cancer

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (4)
Abstract P3-10-06: Expression-based immune signatures as predictors of neoadjuvant targeted-/chemo-therapy response: Experience from the I-SPY 2 TRIAL of ˜1000 patients across 10 therapies

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (4)
Quantitative MHC II protein expression levels in tumor epithelium to predict response to the PD1 inhibitor pembrolizumab in the I-SPY 2 Trial.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Abstract CT003: Analysis of immune cell infiltrates as predictors of response to the checkpoint inhibitor pembrolizumab in the neoadjuvant I-SPY 2 TRIAL

2019 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (3)
Antigen-Presenting Signaling Events in the Tumor Ecology Associate with Response to Anti-PD-1 Treatment in Lung Cancer

2019 Social Science Research Network
Show All
- Source
- Cite
- Save
Citations (0)